This episode was supported by funding from Mylan. ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss the recent biosimilar focus group held at ONS, the key takeaways from that meeting, and how the Society will support nurses as they encounter more biosimilars in practice. Music Credit: "Fireflies and Stardust" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 Episode Notes Check out these resources from today’s episode: The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.  An Oncology Nursing Overview of Biosimilars Biosimilars, Oral Agents, and Drugs Targeting Genetic Mutations Are Creating a Paradigm Shift in Cancer Treatment Novel Therapies: How CAR T Cells and Biosimilars Are Changing Cancer Care Biosimilars: Exploring the History, Science, and Progress Episode 10: How Biosimilars Could Impact the Future of Cancer Care